ROSUVASTATIN NOBEL cpr pell 20 mg 30 pce

7680676050054 CH-67605 C10AA07 07.12.0.

Reimbursement limitations:

ROSUVASNobel

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

ROSUVASTATIN NOBEL cpr pell 20 mg 30 pce
ROSUVASTATIN NOBEL cpr pell 20 mg 30 pce
ROSUVASTATIN NOBEL cpr pell 20 mg 30 pce
1 / 3
google

Details

Product number
6760503
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
rosuvastatinum 20 mg ut rosuvastatinum calcicum, lactosum monohydricum 84.978 mg, calcii carbonas, cellulosum microcristallinum, crospovidonum, hydroxypropylcellulosum, magnesii stearas, aqua purificata, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, copovidonum, E 171, kaolinum ponderosum, natrii laurilsulfas, E 110 5.1 µg, E 120, poly(alcohol vinylicus), silica colloidalis anhydrica, talcum, pro compresso obducto corresp. natrium 6 µg.

Articles (1)

Rosuvastatin NOBEL 20 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/10/2025
Patient information leaflet
Français
15/10/2025
Patient information leaflet
Italien
15/10/2025
Professional SmPC
Allemand
15/10/2025
Professional SmPC
Français
15/10/2025
Professional SmPC
Italien
15/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
84.978 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
5.1 UG Substance HBESI
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
6.0 UG Substance HBESI

Reimbursement information

Public price
CHF 29.20
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2020

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67605
Drug name
Rosuvastatin NOBEL, Filmtabletten
Galenic form
FILM
ATC Code
C10AA07
Authorization status
Z
Dispensation category
B
First authorization
16/12/2019
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration. Vorbeugung kardiovaskulärer Ereignisse bei Erwachsenen mit normalem LDL-Cholesterin Spiegel und erhöhtem Risiko von atherosklerotischen kardiovaskulären Erkrankungen.

Packaging details

Description (FR)
ROSUVASTATIN NOBEL cpr pell 20 mg 30 pce
Description (DE)
ROSUVASTATIN NOBEL Filmtabl 20 mg 30 Stk
Market launch
16/12/2019
Narcotic (BTM)
No

Original drug

Crestor, Filmtabletten
CHF 29.50
View original

Other packaging sizes

ROSUVASTATIN NOBEL cpr pell 5 mg 30 pce
30 TABL
View
ROSUVASTATIN NOBEL cpr pell 5 mg 105 pce
105 TABL
View
ROSUVASTATIN NOBEL cpr pell 5 mg bte 190 pce
190 TABL
View
ROSUVASTATIN NOBEL cpr pell 10 mg 30 pce
30 TABL
View
ROSUVASTATIN NOBEL cpr pell 10 mg 105 pce
105 TABL
View
ROSUVASTATIN NOBEL cpr pell 10 mg bte 190 pce
190 TABL
View
ROSUVASTATIN NOBEL cpr pell 20 mg 105 pce
105 TABL
View
ROSUVASTATIN NOBEL cpr pell 20 mg bte 120 pce
120 TABL
View